Interval Between COVID Vaccine and Other Vaccines

Current guidance from major health agencies is clear: you do not need to wait any set number of days between a COVID-19 vaccine and other vaccines. COVID-19 vaccines can be given at the same visit as flu shots, RSV vaccines, pneumococcal vaccines, and most other routine immunizations. This was not always the recommendation, though. Early in the pandemic, many countries advised a buffer of at least 14 days between a COVID shot and any other vaccine, a cautious stance rooted in uncertainty rather than evidence of harm. The science that has accumulated since then tells a more reassuring story, and understanding how that evidence stacks up can help you make practical scheduling decisions with confidence.

How the Guidance Changed

When the first COVID-19 vaccines received emergency authorization in late 2020 and early 2021, health authorities in many countries recommended spacing them apart from other vaccines by roughly two weeks. The reasoning was straightforward: these were brand-new products, and regulators wanted to be able to clearly attribute any side effects to the right vaccine. If you got a COVID shot and a flu shot on the same day and then developed a fever, it would be difficult to tell which one was responsible.

That spacing recommendation was a precaution, not a reaction to any evidence of danger. As coadministration data began to emerge from clinical trials and real-world surveillance, agencies dropped the waiting period. The U.S. Centers for Disease Control and Prevention updated its guidance to allow same-day administration regardless of the other vaccine type, and similar updates followed in the UK, Canada, and much of Europe. Today, the practical message is that if you are due for a COVID booster and another vaccine at roughly the same time, there is no medical reason to schedule separate appointments.

Getting a COVID Vaccine and a Flu Shot Together

The most common coadministration scenario by far is getting a COVID-19 vaccine alongside a seasonal influenza vaccine. Both tend to be offered in the fall, and pharmacies and clinics routinely give them in the same visit. The safety data here is among the strongest of any vaccine pairing.

A large analysis of reports to the U.S. Vaccine Adverse Event Reporting System (VAERS) looked at people who received a bivalent mRNA COVID-19 vaccine and a seasonal flu shot at the same time. The review did not identify any new or unexpected safety signals beyond what would be expected from either vaccine given alone.¹ In other words, getting both shots on the same day did not produce some new category of adverse event that people would not experience from either shot individually.

A separate study tracking over 1,200 participants found that about 81% of people who received both vaccines at once reported at least one side effect, compared with about 87% in the control group who received only one vaccine. Every specific symptom queried, including injection-site soreness, headache, muscle pain, fatigue, and fever, was actually reported slightly less often in the coadministration group, though none of those differences reached statistical significance.² The takeaway is that getting both shots together does not meaningfully pile on more side effects than getting one alone.

What About Immune Responses When Vaccines Are Combined

A natural worry is that your immune system might get “overwhelmed” by two vaccines at once and not mount a strong enough response to either one. The clinical evidence consistently says this does not happen. Studies measuring antibody levels after coadministration of COVID and flu vaccines have found that immune responses to both vaccines remain robust.

This principle applies broadly: the immune system routinely encounters thousands of foreign substances every day, and two vaccines given at different injection sites stimulate largely independent immune pathways. Pediatric vaccination schedules have long included multiple vaccines at a single visit for exactly this reason. The COVID vaccines are no exception.

One interesting development on this front is the emergence of combination vaccines that include both COVID-19 and influenza components in a single shot. A randomized trial of one such combined mRNA vaccine, mRNA-1083, found that it met noninferiority criteria for immune responses against all matched influenza strains and SARS-CoV-2 compared with giving the vaccines separately. In adults 50 and older, the combined vaccine actually produced higher immune responses against most influenza strains and against SARS-CoV-2 than the separate comparators. Side effects were slightly more frequent with the combination product, but the vast majority were mild to moderate and short-lived.³ If these combination vaccines eventually reach the market, they would simplify the scheduling question entirely.

RSV Vaccines and COVID Shots

Respiratory syncytial virus (RSV) vaccines are relatively new additions to the adult immunization landscape, having been approved for older adults in 2023. With RSV vaccines and COVID boosters both recommended for adults aged 60 and over, the question of whether to get them together comes up frequently.

A phase 3 trial tested coadministration of an RSV vaccine (the adjuvanted prefusion F protein type) and an mRNA COVID-19 vaccine in adults aged 50 and older. The study found that giving both vaccines at the same visit produced neutralizing antibody responses against both RSV subtypes that met predefined noninferiority criteria compared with giving the vaccines separately. People who got both shots at once did report side effects more often than those who got them at separate visits, but the reactions were mostly mild to moderate and resolved within a few days.⁴

The mild uptick in side effects when two vaccines are given at once is a recurring finding across many coadministration studies, and it makes intuitive sense. Two separate immune activations are happening simultaneously, so there is a slightly higher chance of feeling run down for a day or two. For most people, this is a worthwhile tradeoff compared with the inconvenience of two separate clinic visits.

Pneumococcal and Other Adult Vaccines

Less attention has been paid to the combination of COVID-19 vaccines with pneumococcal vaccines, partly because their recommended schedules do not overlap as neatly as fall flu and COVID boosters do. But the available evidence is encouraging. A study of over 600 nursing home residents aged 65 and older found that receiving pneumococcal and influenza vaccines alongside COVID-19 vaccination was protective against COVID-19 hospitalization and COVID-related death.⁵ While this study focused on clinical outcomes rather than the mechanics of coadministration, the finding reinforces that getting multiple vaccines does not undercut the protection any one of them provides.

For other routine adult vaccines, including shingles (Shingrix), Tdap, and hepatitis B, the general principle holds. Health agencies allow them to be given at the same visit as COVID-19 vaccines. Formal coadministration trials for every possible pairing do not exist, because there are simply too many combinations. But the biological rationale is strong, and no safety signals have emerged from the millions of people who have received COVID vaccines alongside other immunizations.

Does the Type of COVID Vaccine Matter

Not all COVID-19 vaccines are built the same way, and some produce noticeably different side-effect profiles on their own. A comparison of the protein-based COVID-19 vaccine (Novavax, NVX-CoV2373) and mRNA-based vaccines found that systemic side effects in the first two days were reported by about 61% of protein-vaccine recipients versus roughly 84% of mRNA-vaccine recipients. Local reactions followed a similar pattern, with about 73% reporting them after the protein vaccine versus about 92% after an mRNA shot.⁶

This difference matters for coadministration because side effects are the main downside of getting two vaccines at once. If you are pairing a COVID shot with another vaccine and you are particularly concerned about how you will feel afterward, the protein-based option might give you a somewhat gentler experience on the COVID side. That said, the choice of COVID vaccine platform should primarily be driven by availability and your provider’s recommendation, not by coadministration planning alone.

Why People Still Space Their Vaccines Out

Despite the green light from health agencies, many people still choose to get their vaccines on separate days. A cross-sectional survey of Canadian adults explored why. The most common reason for not coadministering flu and COVID vaccines was simply timing: about 35% of respondents said they had already gotten their COVID vaccine before the flu shot became available, and another 14% cited scheduling conflicts. Only about 8% said they were worried about extra side effects from getting both at once, and roughly 5% believed that two vaccines at the same time would be “too much” for their body.⁷

In other words, the biggest barrier is logistics, not fear. COVID boosters and flu shots are not always available at the same time, especially if you get your COVID vaccine early in the season before flu vaccine supplies arrive. About 11% of respondents did not even know coadministration was an option, and a small but notable 4% said a healthcare provider had told them not to get the vaccines together, which does not align with current guidance. Among those who were interested in coadministration, the top motivators were convenience and saving time.

The perception gap between COVID vaccines and flu vaccines is worth noting. Research on public attitudes has found that people often view the two vaccines quite differently, with more hesitancy around COVID vaccines. One recommendation from researchers studying this divergence is that clinics offering both vaccines should lead their messaging with the flu shot, since it is the more familiar and widely accepted product, and address COVID-specific concerns like the perceived limits of protection from prior infection.⁸

Practical Scheduling Tips

If you are trying to optimize your vaccine schedule, a few practical points are worth keeping in mind. First, there is no medical benefit to spacing vaccines apart. You will not get a stronger immune response by waiting two weeks between your flu shot and your COVID booster. The immune system handles simultaneous challenges just fine.

Second, if you know that vaccine side effects tend to hit you hard, you might prefer to get both shots on a Friday or before a day off. The most common reactions, including sore arms, fatigue, and headache, usually peak around 12 to 24 hours after vaccination and resolve within a couple of days. Getting two vaccines can modestly increase the chance of these symptoms, but not their severity or duration in most cases.

Third, each vaccine should be given in a different injection site. Pharmacists and nurses routinely do this by default, one in each arm. If you are getting three vaccines at once, the third can go in the same arm as one of the others, just a couple of inches apart.

Fourth, if for whatever reason you do end up spacing your vaccines a few weeks apart, that is perfectly fine too. The “no minimum interval” guidance means you can get them on the same day, but it also means you can get them a day apart, a week apart, or a month apart without any concern about interference. The flexibility runs in both directions.

When Spacing Might Still Make Sense

There are a few narrow circumstances where a provider might suggest separating vaccines in time. People who are moderately or severely immunocompromised sometimes follow different vaccination schedules, and their providers may want to monitor responses to each vaccine individually. This is an individualized medical decision rather than a blanket rule.

Another practical scenario involves side-effect tracking for people with specific health conditions. If your doctor is trying to determine whether a new medication or health change is affecting how you respond to vaccines, they might prefer to isolate each vaccine so any reaction can be clearly attributed. This is the same logic that drove the early pandemic spacing guidance, applied on a case-by-case basis rather than as a population-wide policy.

For children, the situation depends partly on which COVID vaccine formulations are authorized for their age group and what other routine shots they are due for. Pediatricians generally follow the same coadministration rules: COVID vaccines can be given alongside other childhood immunizations. The practical challenge for parents is that vaccine appointments for young children already involve multiple shots, and adding a COVID dose to the mix can mean three or four injections in one visit. Some parents understandably prefer to split those across two visits for comfort reasons, and that is a reasonable personal choice as long as the child completes the full schedule.

The Move Toward Combination Vaccines

The long-term answer to the scheduling question may be combination products that bundle COVID and flu protection into a single injection. As noted earlier, clinical trials for at least one mRNA-based combination vaccine have shown promising results, with immune responses meeting or exceeding those of the individual vaccines given separately.³ Several pharmaceutical companies are pursuing similar products.

If these combination vaccines gain regulatory approval, they could meaningfully simplify fall vaccination campaigns. Instead of offering two shots and trying to convince people to get both on the same visit, clinics could offer a single injection covering both respiratory threats. For the sizable fraction of the public that finds coadministration logistically inconvenient or conceptually unappealing, a one-shot approach removes the scheduling puzzle altogether. The side-effect profile of combination products will be watched closely, since the slightly higher reactogenicity observed in early trials could become a practical barrier if people associate the combo shot with feeling worse afterward. Still, mild and short-lived side effects from a single visit are widely considered preferable to the risk of skipping one vaccine because scheduling two appointments felt like too much hassle.

Making Vaccines More Accessible at the Same Time

Getting people vaccinated is not just about resolving safety questions. Accessibility plays a major role in whether people actually show up. Mobile vaccination units, which became common during the COVID-19 pandemic, have shown real impact on uptake. An observational study in the United States found that each additional day a mobile vaccine clinic operated in a given area substantially decreased the odds that no vaccinations occurred that week in that area.⁹ A similar study in the UK estimated that neighborhoods visited by mobile units saw vaccination rates roughly 23% higher in the three weeks after the visit than they would have seen otherwise, accounting for an estimated 3,700 additional vaccinations over a short follow-up period.¹⁰

These findings are relevant to the coadministration question because mobile clinics and pharmacy-based campaigns are natural settings for offering multiple vaccines at once. If someone walks into a mobile unit for a flu shot and a COVID booster is also available, the barrier to getting both drops to near zero. The logistical friction that the Canadian survey identified as the top reason people do not coadminister, including timing mismatches and lack of awareness, can be addressed by making both vaccines available in the same place at the same time, especially in underserved communities where scheduling a separate appointment at a different location might mean the second vaccine never happens.